Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006864 |
---|---|
Receipt number | R000007989 |
Scientific Title | A randomized phase l study on TS-1+CDDP+CPT-11(IPS) therapy for patients with advanced/metastatic gastric cancer(HERBIS-4A) (OGSG 1106) |
Date of disclosure of the study information | 2011/12/10 |
Last modified on | 2023/09/24 13:36:02 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/12/08 23:53:58 | ||
2 | Update | 2012/06/24 22:06:00 | Recruitment status |
|
3 | Update | 2012/06/24 22:10:59 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Organization1 Address1 Tel1 Email1 |
|
4 | Update | 2012/06/24 22:26:36 | Public title Public title Acronym Acronym |
|
5 | Update | 2013/12/10 07:06:43 | Anticipated trial start date |
|
6 | Update | 2014/11/15 14:59:49 | Last follow-up date |
|
7 | Update | 2014/11/15 15:02:49 | Email Institutions |
|
8 | Update | 2014/12/16 21:35:44 | Last follow-up date |
|
9 | Update | 2015/06/10 00:35:58 | Email |
|
10 | Update | 2015/12/09 23:00:25 | Last follow-up date |
|
11 | Update | 2016/06/09 21:22:53 | Name of primary person or sponsor Organization |
|
12 | Update | 2017/06/15 23:23:25 | Recruitment status Last follow-up date |
|
13 | Update | 2018/01/14 19:55:57 | Public title Public title Acronym Acronym |
|
14 | Update | 2018/01/14 19:58:56 | Last follow-up date |
|
15 | Update | 2018/01/14 20:06:52 | Narrative objectives1 Narrative objectives1 Developmental phase Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
16 | Update | 2018/04/30 23:41:32 | Email |
|
17 | Update | 2018/05/10 20:29:53 | Email |
|
18 | Update | 2018/06/18 22:55:54 | Last follow-up date |
|
19 | Update | 2018/08/01 22:04:25 | UMIN ID1 |
|
20 | Update | 2018/08/01 22:06:50 | Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL |
|
21 | Update | 2018/12/12 20:34:09 | Recruitment status Date analysis concluded |
|
22 | Update | 2020/01/05 18:12:20 | Date of IRB |
|
23 | Update | 2020/01/05 20:59:53 | Last follow-up date Date analysis concluded |
|
24 | Update | 2023/09/24 13:36:02 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |